NCT05300906

Brief Summary

This study will investigate the effectiveness of an engagement-based personalized 2-week mobile wellbeing intervention, vs the effectiveness of a non-personalized 2-week mobile wellbeing intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 3, 2022

Completed
26 days until next milestone

First Posted

Study publicly available on registry

March 29, 2022

Completed
3 days until next milestone

Study Start

First participant enrolled

April 1, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2023

Completed
Last Updated

June 8, 2023

Status Verified

June 1, 2023

Enrollment Period

8 months

First QC Date

March 3, 2022

Last Update Submit

June 7, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change from baseline in wellbeing, measured with the Mental Health Continuum Short Form, at 3 weeks.

    Wellbeing will be measured in an online survey, using the Mental Health Continuum Short Form. This validated scale consists of 14 items. The scale's total scores range from 14 to 84, with higher scores indicating higher wellbeing and thus better outcomes.

    baseline, 3 weeks

  • Change from baseline in depressive symptoms, measured with the Patient Health Questionnaire-9, at 3 weeks.

    Depressive symptoms will be measured in an online survey, using the Patient Health Questionnaire-9. This validated scale consists of 9 items. The scale's total scores range from 0 to 27, with higher scores indicating higher depressive symptoms and thus worse outcomes.

    baseline, 3 weeks

  • Change from baseline in anxiety symptoms, measured with the Generalized Anxiety Disorder 7-item scale, at 3 weeks.

    Depressive symptoms will be measured in an online survey, using the Generalized Anxiety Disorder 7-item scale. This validated scale consists of 6 items. The scale's total scores range from 0 to 21, with higher scores indicating higher anxiety symptoms and thus worse outcomes.

    baseline, 3 weeks

Secondary Outcomes (7)

  • Adherence

    after 3 weeks

  • Engagement, measured with the TWente Engagement with Ehealth Technologies Scale.

    after 1 day

  • Engagement, measured with the TWente Engagement with Ehealth Technologies Scale.

    after 7 days

  • Engagement, measured with the TWente Engagement with Ehealth Technologies Scale.

    after 3 weeks

  • Change from baseline in wellbeing, measured with the Mental Health Continuum Short Form, at 8 weeks.

    baseline, 8 weeks

  • +2 more secondary outcomes

Study Arms (2)

Personalized

EXPERIMENTAL

Participants in the personalized arm will receive the optimal combination of content, feedback and design, based on their baseline engagement scores.

Behavioral: personalized 2-week mobile wellbeing intervention

non-personalized

ACTIVE COMPARATOR

Participants in the non-personalized arm will receive a randomly selected version of the 27 possible interventions, regardless of their baseline engagement scores.

Behavioral: non-personalized 2-week mobile wellbeing intervention

Interventions

For the study, 27 versions of a 2-week mobile wellbeing intervention are created. These versions vary on content (Cognitive Behavioral Therapy, meaning, positive psychology), feedback (text, text with avatar, pre-recorded video) and design (non-gamified, competitively gamified, storyline gamified). At baseline, participants preview all variations and indicate their expected engagement. Participants in the personalized condition will receive the optimal combination of content, feedback and design, based on their baseline engagement scores. Each version of the intervention consists of a module per day. Each module contains psychoeducation and exercises based on content of the version. Moreover, each module contains pre-specified general feedback and supportive messages.

Personalized

For the study, 27 versions of a 2-week mobile wellbeing intervention are created. These versions vary on content (Cognitive Behavioral Therapy, meaning, positive psychology), feedback (text, text with avatar, pre-recorded video) and design (non-gamified, competitively gamified, storyline gamified). At baseline, participants preview all variations and indicate their expected engagement. Participants in the non-personalized condition will receive a random version of the intervention. Each version of the intervention consists of a module per day. Each module contains psychoeducation and exercises based on content of the version. Moreover, each module contains pre-specified general feedback and supportive messages.

non-personalized

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • at least mild depressive or anxiety complaints; \>4 Generalized Anxiety Disorder 7-item scale OR Patient Health Questionnaire 9-item scale
  • access to smartphone with internet
  • adequate English literacy

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Twente

Enschede, Netherlands

Location

Study Officials

  • Saskia M Kelders, PhD

    University of Twente

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Participants will not be informed about their randomized condition (personalized or non-personalized), but it is likely that they will infer it from the intervention that they receive.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: participants are randomized to either the personalized or the non-personalized intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 3, 2022

First Posted

March 29, 2022

Study Start

April 1, 2022

Primary Completion

December 1, 2022

Study Completion

February 1, 2023

Last Updated

June 8, 2023

Record last verified: 2023-06

Locations